Search - tctmd.com

Displaying 201 - 220 of 6832

Sort: Relevancy | Date

Presentation TCT 2025

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mostafa Ali

October 26, 2025

Presentation TCT 2025

How Do I Derisk TAVR in Challenging or Previously Treated Aortic Anatomy

Presenter: Oscar A. Mendiz

October 26, 2025

Presentation TCT 2025

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

Presenter: Sammy Elmariah

October 26, 2025

Presentation TCT 2025

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

Presenter: Mahsa Rezasoltani

October 26, 2025

Presentation TCT 2025

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

Presenter: Philipp Kiefer

October 26, 2025

Presentation TCT 2025

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

Presenter: Hasnan M. Ijaz

October 26, 2025

Presentation TCT 2025

TCT 641: 5-Year Outcomes of New Generation Balloon Expandable Valve Replacement in Patients with End-Stage Renal Disease

Presenter: Hidemasa Shitan

October 26, 2025

Presentation TCT 2025

TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR

Presenter: Robert Kay

October 26, 2025

Presentation TCT 2025

TCT 116: Burden of Tricuspid Valve Regurgitation in Early Pacemaker Recipients After TAVR: A Single Center Study

Presenter: Massimo Baudo

October 26, 2025

Presentation TCT 2025

TCT 1410: Safe Passage: Prevention of Left Main Coronary Artery Occlusion During TAVR

Presenter: Ammer Aldairi

October 26, 2025

Presentation TCT 2025

TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study

Presenter: Shayan Khan

October 26, 2025

Presentation TCT 2025

TCT 1409: Single-Setting Complex PCI and TAVR in Severe AS With Heavily Calcified Anomalous RCA Origin

Presenter: Ying-Hsien Chen

October 26, 2025

Presentation TCT 2025

TCT 1381: TAV in TAV in TAV: Balloon Expandable Valve for Failed Self Expanding Inside of Self Expanding TAVR Valve

Presenter: Robert Stoler

October 26, 2025

Presentation TCT 2025

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

Presenter: Chaitanya Tumuluri

October 26, 2025

Presentation TCT 2025

TAVR Device Selection Considerations (SMART)

Presenter: Howard C. Herrmann

October 26, 2025

Presentation TCT 2025

TCT 74: Survival Outcomes Following TAVR in Tafamidis-Treated Cardiac Amyloidosis: A Propensity-Matched Analysis

Presenter: Tamari Lomaia

October 26, 2025

Presentation TCT 2025

TCT 114: Impact of New Pacemaker Implantation After TAVR in Low/Intermediate-Risk Patients: A Propensity-Matched Analysis from a United States Registry

Presenter: Roger Renault Godinho

October 26, 2025

Presentation TCT 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Marvin H. Eng

October 26, 2025

Presentation TCT 2025

TCT 1408: Transcatheter Aortic Valve Replacement (TAVR) and the Left Main Challenge: Risk Stratification and Bailout Strategies

Presenter: Enhua Wang

October 26, 2025

Presentation TCT 2025

TCT 1380: Not ReViVed by the Valve: A Challenging Case of ViViV TAVR for ViV TAVR Failure

Presenter: Thomas Etheridge

October 26, 2025

Advertisement

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

How Do I Derisk TAVR in Challenging or Previously Treated Aortic Anatomy

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

TCT 641: 5-Year Outcomes of New Generation Balloon Expandable Valve Replacement in Patients with End-Stage Renal Disease

TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR

TCT 116: Burden of Tricuspid Valve Regurgitation in Early Pacemaker Recipients After TAVR: A Single Center Study

TCT 1410: Safe Passage: Prevention of Left Main Coronary Artery Occlusion During TAVR

TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study

TCT 1409: Single-Setting Complex PCI and TAVR in Severe AS With Heavily Calcified Anomalous RCA Origin

TCT 1381: TAV in TAV in TAV: Balloon Expandable Valve for Failed Self Expanding Inside of Self Expanding TAVR Valve

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

TAVR Device Selection Considerations (SMART)

TCT 74: Survival Outcomes Following TAVR in Tafamidis-Treated Cardiac Amyloidosis: A Propensity-Matched Analysis

TCT 114: Impact of New Pacemaker Implantation After TAVR in Low/Intermediate-Risk Patients: A Propensity-Matched Analysis from a United States Registry

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

TCT 1408: Transcatheter Aortic Valve Replacement (TAVR) and the Left Main Challenge: Risk Stratification and Bailout Strategies

TCT 1380: Not ReViVed by the Valve: A Challenging Case of ViViV TAVR for ViV TAVR Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content